| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 20.261 | 54.996 | 68.241 | 80.614 | 79.413 | 90.176 | 90.063 | 138.399 |
| Total Income - EUR | 0 | 0 | 20.261 | 54.996 | 68.247 | 82.691 | 79.426 | 90.263 | 90.115 | 138.429 |
| Total Expenses - EUR | 98 | 97 | 6.646 | 21.842 | 25.256 | 30.676 | 32.315 | 32.867 | 33.093 | 39.659 |
| Gross Profit/Loss - EUR | -98 | -97 | 13.615 | 33.154 | 42.991 | 52.016 | 47.111 | 57.396 | 57.023 | 98.770 |
| Net Profit/Loss - EUR | -98 | -97 | 13.098 | 32.604 | 42.308 | 51.250 | 46.333 | 56.603 | 56.143 | 94.700 |
| Employees | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Andalex Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 92 | 91 | 89 | 88 | 913 | 15.984 | 17.559 | 18.076 | 15.231 | 13.257 |
| Current Assets | 45 | 45 | 31.939 | 49.756 | 72.794 | 90.076 | 40.610 | 96.496 | 51.330 | 101.200 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.157 | 0 | 0 |
| Receivables | 0 | 0 | 12.774 | 16.629 | 17.273 | 22.090 | 14.860 | 15.781 | 22.283 | 54.208 |
| Cash | 45 | 45 | 19.165 | 33.126 | 55.522 | 67.986 | 25.750 | 77.557 | 29.048 | 46.992 |
| Shareholders Funds | -100 | -99 | 13.001 | 32.509 | 55.001 | 86.442 | 46.373 | 72.703 | 56.184 | 94.740 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 236 | 234 | 19.027 | 17.335 | 18.706 | 19.618 | 11.797 | 41.869 | 10.601 | 19.716 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Andalex Medical Srl